NME2 modulates HCC progression through 4EBP1 phosphorylation and autophagy regulation independent of mTOR

Wei Chen1, Da-Chen Zhou2, Chen-Hui Rui2

  • 1Department of General Surgery, The Second People's Hospital of Hefei, Anhui, China.

PubMed
Abstract

Insights

Nucleoside diphosphate kinase 2 (NME2) drives hepatocellular carcinoma (HCC) progression by affecting 4EBP1 phosphorylation and autophagy. Targeting NME2 offers a potential therapeutic strategy for HCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Understanding novel molecular drivers of HCC progression is critical for developing effective therapies.

Purpose of the Study:

  • To investigate the role of nucleoside diphosphate kinase 2 (NME2) in HCC.
  • To assess the therapeutic potential of targeting NME2 in HCC.

Main Methods:

  • Analysis of NME2 expression using TCGA transcriptome data and immunohistochemistry.
  • Assessment of NME2's impact on HCC cell proliferation and autophagy via knockdown/overexpression.
  • Exploration of the NME2-4EBP1 phosphorylation relationship using site-specific mutations.

Main Results:

  • NME2 overexpression correlates with poor prognosis in HCC patients.
  • NME2 knockdown inhibits HCC cell proliferation and induces autophagy.
  • NME2 modulates 4EBP1 phosphorylation (Thr37/46) independently of mTOR, impacting eIF4F complex formation and autophagy.

Conclusions:

  • NME2 is a key regulator of HCC development through mTOR-independent modulation of 4EBP1 phosphorylation and autophagy.
  • NME2 represents a promising therapeutic target for HCC.
  • Further research is warranted to explore NME2's mechanisms and clinical applications in HCC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K